Machine Learning-Guided Generation of Novel Pseudo-Natural Products: Applications to Accelerate Drug Discovery

Authors:

Abstract
Natural products (NPs) are a critical source for drug discovery, and artificial intelligence (AI) is utilized to improve the efficiency of NP-based drug discovery. However, the existing AI-driven models typically generate a library of pseudo-natural products that only covers a small portion of the chemical space and the compounds were also restricted by poor drug-likeness profiles. Herein, the GPT1 is developed to generate diverse pseudo-natural products with excellent validity, uniqueness, and novelty while retaining molecular features similar to the training set. Subsequently, the Augmented Hill-Climb (AHC) strategy is employed to generate synthetically accessible compounds with enhanced drug-likeness. Using the integrated NPDL-GEN model (GPT1 + AHC), compounds G1-G5 were obtained, exhibiting significantly improved drug-likeness profiles. Furthermore, the pseudo-natural products H1-H3 generated via transfer learning also possess potent anti-inflammatory activities. Thus, our developed machine learning models can accelerate NP-based drug discovery.
Funding Information
  • Graduate Research and Innovation Projects of Jiangsu Province (KYCX24 2146)
  • Nanjing University of Chinese Medicine (01303801902, JBGS202407, NZY81703342, ZYXJC2024-007, ZYXJC2024-010, ZYXYL2024-007)
  • Natural Science Foundation of Jiangsu Province (BK20211301)
  • Shanghai Municipal Education Commission (SHJWAIJK241205)
  • National Natural Science Foundation of China (32400527, U2102201, U24A20785)
  • Open Project of Jiangsu Province Engineering Research Center of TCM Intelligence Health Service (ZHZYY202413)
  • Chinese Medicine Leading Talent Project of Jiangsu Province (SLJ0321)

This publication has 63 references indexed in Scilit: